Beth Karlan, MD

Cedars-Sinai, UCLA

KarlanDr. Karlan is Director of the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology and Director of the Gilda Radner Hereditary Cancer Program. She holds the Board of Governors Chair in Gynecologic Oncology. Dr. Karlan is also Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Board certified in Obstetrics and Gynecology and in Gynecologic Oncology, Dr. Karlan has been awarded research grants from the Department of Defense, National Institutes of Health and the American Cancer Society. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. Dr. Karlan has written over 200 peer reviewed articles, and is Editor-in-Chief of the publications Gynecologic Oncology and Gynecologic Oncology Case Reports.

Dr. Karlan served as President of SGO in 2005-2006 and has held leadership positions with the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology, and the Board of Governors of the American College of Surgeons. Dr. Karlan holds an Early Detection Professorship with the American Cancer Society.

Spotlight

This special section in Self Magazine features a GYN surgeon and 34-year-old (at the time of diagnosis) patient.

Awareness

This year’s National Race to End Women’s Cancer aims to spread the word that all women should Love Your Ladyparts! Check out site’s new features and join the MOVEMENT.

Research

The Foundation’s research award winners will be notified in January. Thank you to all who sent in their applications.

Education

The next Ovarian Cancer Survivors Course will be Saturday, Nov. 1, 2014 in D.C. For more information on educational events and courses, click here.